Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Logothetis
Eleni Efstathiou
Fil Manuguid
Peter Kirkpatrick

Showing results (1-10 of 476) with videos related to

Pageof 48
Sort By:
Nature Reviews. Drug Discovery|August 2, 2011
Abiraterone acetateChristopher J Logothetis, Eleni Efstathiou, Fil Manuguid, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 23, 2006
Review of late complications of treatment and late relapse in testicular cancerEleni Efstathiou, Christopher J Logothetis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
A new therapy paradigm for prostate cancer founded on clinical observationsEleni Efstathiou, Christopher J Logothetis
Nature Reviews. Urology|May 9, 2009
Prostate cancer: thalidomide for prostate cancer: is there progress?Eleni Efstathiou, Christopher J Logothetis
Nature Reviews. Drug Discovery|March 2, 2011
Eribulin mesylateTimothy K Huyck, William Gradishar, Fil Manuguid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Informative clinical investigation: a demanding taskmasterEleni Efstathiou, Jeri Kim, Christopher J Logothetis
European Urology|July 14, 2019
Prostate Cancer: Quo Vadis?Christopher J Logothetis, Ana Aparicio, Filippos Koinis, et al.
Future Oncology (London, England)|April 21, 2021
Real-world treatment patterns and healthcare resource use in patients with acute myeloid leukemia in Western EuropeMadhusudan Kabra, Luana Margotto, Fil Manuguid
BMC Medical Genomics|August 6, 2009
Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression dataIvan P Gorlov, Jinyoung Byun, Olga Y Gorlova, et al.
Cancer Discovery|July 2, 2013
Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancerChristopher J Logothetis, Gary E Gallick, Sankar N Maity, et al.
Pageof 48

Showing results (1-10 of 476) with videos related to

Sort By:
Pageof 48
Nature Reviews. Drug Discovery|August 2, 2011
Abiraterone acetateChristopher J Logothetis, Eleni Efstathiou, Fil Manuguid, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 23, 2006
Review of late complications of treatment and late relapse in testicular cancerEleni Efstathiou, Christopher J Logothetis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
A new therapy paradigm for prostate cancer founded on clinical observationsEleni Efstathiou, Christopher J Logothetis
Nature Reviews. Urology|May 9, 2009
Prostate cancer: thalidomide for prostate cancer: is there progress?Eleni Efstathiou, Christopher J Logothetis
Nature Reviews. Drug Discovery|March 2, 2011
Eribulin mesylateTimothy K Huyck, William Gradishar, Fil Manuguid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Informative clinical investigation: a demanding taskmasterEleni Efstathiou, Jeri Kim, Christopher J Logothetis
European Urology|July 14, 2019
Prostate Cancer: Quo Vadis?Christopher J Logothetis, Ana Aparicio, Filippos Koinis, et al.
Future Oncology (London, England)|April 21, 2021
Real-world treatment patterns and healthcare resource use in patients with acute myeloid leukemia in Western EuropeMadhusudan Kabra, Luana Margotto, Fil Manuguid
BMC Medical Genomics|August 6, 2009
Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression dataIvan P Gorlov, Jinyoung Byun, Olga Y Gorlova, et al.
Cancer Discovery|July 2, 2013
Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancerChristopher J Logothetis, Gary E Gallick, Sankar N Maity, et al.
Pageof 48